Lipid Metabolism Adaptability in Glioblastoma: Mechanisms, Tumor Microenvironment Alterations, and Potential Therapeutic Avenues
-
By
-
Weiqi Wu
-
Minying Liu
-
Qi Lv
-
Zixun Ming
-
Longchang Song
-
Junsheng Chu
-
July 21, 2026
Clinical Scorecard: Lipid Metabolism Adaptability in Glioblastoma: Mechanisms, Tumor Microenvironment Alterations, and Potential Therapeutic Avenues
At a Glance
| Category | Detail |
|---|
| Condition | Glioblastoma (GBM) |
| Key Mechanisms | Lipid metabolic reprogramming, tumor microenvironment remodeling, immune suppression, therapeutic resistance |
| Target Population | Adults with glioblastoma |
| Care Setting | Oncology and neuro-oncology |
Key Highlights
- Lipid metabolism is a critical hallmark of GBM progression and therapeutic resistance.
- GBM cells exhibit dynamic lipid metabolic plasticity in response to hypoxia and nutrient deprivation.
- Lipid metabolic alterations contribute to immune suppression and tumor microenvironment formation.
- Emerging technologies enhance understanding of lipid metabolic heterogeneity in GBM.
- Targeting lipid metabolic pathways may improve treatment sensitivity and overcome resistance.
Guideline-Based Recommendations
Diagnosis
- Assess lipid metabolic pathways as part of GBM characterization.
Management
- Consider targeting lipid metabolism in therapeutic strategies for GBM.
Monitoring & Follow-up
- Evaluate lipid metabolic activity in response to treatment.
Risks
- Monitor for therapeutic resistance linked to lipid metabolic adaptations.
Patient & Prescribing Data
Patients diagnosed with glioblastoma
Lipid metabolic reprogramming may influence treatment outcomes and resistance.
Clinical Best Practices
- Integrate lipid metabolic assessment in GBM treatment planning.
- Utilize multi-omics approaches to identify metabolic vulnerabilities in GBM.
Related Resources & Content
